Publication | Closed Access

Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells

InflammationRheumatologyComprehensive Transcriptome AnalysisWhite Blood CellsAnti-inflammatoryAutoimmune DiseaseRheumatoid DisorderImmunologyChronic InflammationPathologyAutoimmunityInflammatory Rheumatic DiseaseRheumatoid Arthritis PatientsImmunotherapyMedicineRheumatoid Arthritis